N46.121 Oligospermia due to drug therapy

Name of the Condition

• Oligospermia due to drug therapy

Summary

Oligospermia due to drug therapy is a condition characterized by a reduced sperm count in the ejaculate resulting from the use of certain medications. It is a specific cause of male infertility, where sperm production or function is impaired by pharmacological agents rather than underlying structural or physiological abnormalities.

Causes

Causes include exposure to medications that interfere with spermatogenesis, such as certain chemotherapeutic agents, anabolic steroids, antihypertensives, or hormonal therapies. These drugs may disrupt hormone levels, testicular function, or sperm production processes.

Risk Factors

Use of medications known to affect sperm production, such as chemotherapy, long-term anabolic steroid use, or certain antihypertensives, increases risk. The duration and dosage of drug therapy may also influence the likelihood of developing this condition.

Symptoms

Symptoms are typically related to infertility, such as difficulty conceiving with a partner. Underlying issues like hormonal imbalances or reduced semen volume may also be present, depending on the specific drug and its effects.

Diagnosis

Diagnosis involves semen analysis to confirm low sperm count, followed by a detailed medication history to identify potential drug-related causes. Hormone testing may be performed to assess reproductive hormone levels, and additional evaluations may rule out other contributing factors.

Treatment Options

Treatment focuses on discontinuing or modifying the causative drug, if clinically appropriate. Alternative medications with less impact on sperm production may be considered. In some cases, assisted reproductive technologies or fertility preservation may be recommended.

Prognosis and Follow-Up

Prognosis depends on the reversibility of the drug's effects and the duration of exposure. Sperm count may improve after discontinuation of the offending agent, but recovery timelines vary. Follow-up semen analysis and hormone testing may be used to monitor progress.

Complications

Complications include persistent infertility if sperm count does not recover, or the need for long-term fertility interventions. Psychological distress related to infertility may also occur.

Lifestyle & Prevention

Prevention involves careful medication selection and monitoring for patients at risk of drug-induced oligospermia. Discussing fertility risks with healthcare providers before starting certain therapies may help mitigate potential effects.

When to Seek Professional Help

Seek medical attention if infertility concerns arise, especially after starting new medications. Prompt evaluation can help identify drug-related causes and guide appropriate management.

Tips for Medical Coders

Document the specific drug therapy associated with the oligospermia, as this is essential for accurate coding. Ensure the medical record supports the causal relationship between the medication and the reduced sperm count. Include details about the drug's mechanism or known effects on spermatogenesis when available.